As part of this agreement, Trace Medical will leverage its national distribution network to offer HME providers exclusive access to rent Tablo and meet the growing demand of dialysis patients seeking treatment at home. Greg Apostolou, Chief Executive Officer of Trace Medical, stated, “We are excited to work with Outset to fill an obvious need in dialysis treatment. Our chairman was recently diagnosed with renal disease and experienced first-hand the treatment gaps for patients. Together, we see an opportunity for Trace to utilize our national distribution platform and customer base which serves approximately 30 million patients annually to address these gaps. After months of planning with the talented team at Outset Medical, we are confident in our collective abilities to serve all healthcare channels with Tablo and make a meaningful difference in patient experience and clinical outcomes.”
Read More: https://www.businesswire.com/news/home/20231004237474/en/Trace-Medical-Outset-Medical-sign-long-term-distribution-agreement-for-Tablo%C2%AE-Hemodialysis-System
Trace Medical & Outset Medical sign long-term distribution agreement for Tablo® Hemodialysis System10/3/2023
Via: Business Wire Comments are closed.
|
Archives
October 2023
|